Rhythm Control Better Prevents Stroke than Rate Control in Patients with Concomitant Hypertrophic Cardiomyopathy and

Shang-Ju Wu1,2, Yun-Yu Chen1,3,4, Yu-Shan Chien1,2,5,6

  • 1Cardiovascular Center, Taichung Veterans General Hospital, Taichung.

Acta Cardiologica Sinica
|January 8, 2025
PubMed

Insights

Rhythm control therapy significantly reduced stroke risk in patients with atrial fibrillation (AF) and hypertrophic cardiomyopathy (HCM). This approach, primarily using medication, proved more effective than rate control for stroke prevention in long-term follow-up.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Clinical Research

Background:

  • Atrial fibrillation (AF) is a known risk factor for stroke and mortality.
  • The impact of rhythm control on stroke risk in patients with concomitant hypertrophic cardiomyopathy (HCM) is not well-established.

Purpose of the Study:

  • To investigate whether rhythm control therapy reduces stroke risk in patients diagnosed with both atrial fibrillation and hypertrophic cardiomyopathy.
  • To compare the effectiveness of rhythm control versus rate control strategies in preventing adverse cardiovascular events in this patient population.

Main Methods:

  • A cohort of 178 adult patients with both AF and HCM was identified from the Taiwan National Health Insurance Database.
  • Patients were categorized into rhythm control (antiarrhythmic medications or catheter ablation) or rate control (rate-controlling medications) groups.
  • A multivariable Cox regression model was employed to assess the hazard ratio for adverse cardiovascular events, including stroke.

Main Results:

  • The rhythm control group (99 patients) demonstrated a significantly lower risk of stroke compared to the rate control group (79 patients) over a mean follow-up of 6.47 years (adjusted HR: 0.380, p = 0.031).
  • This stroke risk reduction benefit persisted even after excluding patients who underwent catheter ablation (adjusted HR: 0.380, p = 0.037).
  • The protective effect of rhythm control on stroke risk was independent of oral anticoagulant use.

Conclusions:

  • Rhythm control, primarily through pharmacological means, is more effective than rate control in preventing stroke among patients with both AF and HCM.
  • The findings suggest a long-term benefit of maintaining sinus rhythm in this specific patient cohort.
  • Rhythm control offers a valuable strategy for mitigating stroke risk in patients with AF and HCM, irrespective of antithrombotic therapy.
Abstract

Related Concept Videos

Disturbances in Heart Rhythm01:28

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
895
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
770
Pulse rhythm01:30

Pulse rhythm

Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
758
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
707
Decreased pulse rate01:14

Decreased pulse rate

Bradycardia is a medical condition in which the heart rate is slower than normal. It occurs when the heart's natural pacemaker, the sinus node, generates slower electrical impulses than the standard rhythm. In adults, bradycardia is diagnosed when the pulse rate falls below 60 beats per minute, indicating a deviation from the normal heart rate range.
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
531
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
886